Jaguar Health, Inc. Announces 1-for-15 Reverse Stock Split

What Happened
Jaguar Health, Inc. announced a one-for-fifteen (1-for-15) reverse stock split of its common stock, effective 12:01 a.m. Eastern Time on September 17, 2026. The company’s board implemented the split under authority previously approved by stockholders on April 20, 2026 (which authorized a reverse split between 1-for-15 and 1-for-150). The Twelfth Amendment to the company’s certificate of incorporation reflecting the reverse split was filed with the Delaware Secretary of State on September 14, 2026. The company issued a press release on September 15, 2026, announcing the effectuation of the reverse split.

Key Details

• Reverse split ratio: 1-for-15; effective date/time: Sept. 17, 2026 at 12:01 a.m. ET.
• Filing/approval: Stockholders approved amendment on April 20, 2026; amendment filed Sept. 14, 2026.
• Post-split CUSIP: 47010C854; trading on Nasdaq will continue on a split-adjusted basis.
• Effects: Outstanding shares, option/warrant share counts and equity plan reserves will be reduced proportionally; exercise/conversion prices for options and warrants increase proportionally; no change to total authorized common or preferred shares; fractional shares will be paid in cash. Equiniti Trust Company, LLC is exchange agent; holders in street name need take no action.

Why It Matters
A reverse stock split reduces the number of outstanding shares and increases the per-share figures proportionally, which can affect trading price per share, liquidity, and the appearance of share metrics. Investors should note the proportional adjustment to option and warrant share amounts and strike/conversion prices, the cash-out treatment of fractional shares, and that trading will continue on Nasdaq on a split-adjusted basis. Holders of record will receive communications from the exchange agent; investors holding shares through brokers do not need to act.